ErbB4 promotes cyclooxygenase-2 expression and cell survival in colon epithelial cells

This publication has 47 references indexed in Scilit:

• Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium
  Journal of Clinical Investigation, 2009
• Suppression of breast cancer cell growth by a monoclonal antibody targeting cleavable ErbB4 isoforms
  Oncogene, 2009
• The ErbB4 Growth Factor Receptor Is Required for Colon Epithelial Cell Survival in the Presence of TNF
  Gastroenterology, 2009
• System-wide Investigation of ErbB4 Reveals 19 Sites of Tyr Phosphorylation that Are Unusually Selective in Their Recruitment Properties
  Chemistry & Biology, 2008
• Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe
  Oncogene, 2008
• Lysophosphatidic Acid Promoting Corneal Epithelial Wound Healing by Transactivation of Epidermal Growth Factor Receptor
  Investigative Opthalmology & Visual Science, 2007
• Protease-Activated Receptor-2 Activation in Gastric Cancer Cells Promotes Epidermal Growth Factor Receptor Trans-Activation and Proliferation
  The American Journal of Pathology, 2006
• ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti‐cancer therapy
  International Journal of Cancer, 2006
• The ErbB-4 s80 intracellular domain is a constitutively active tyrosine kinase
  Oncogene, 2005
• Impaired differentiation and lactational failure ofErbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5
  Development, 2003